Effects of gastrokine‑2 expression on gastric cancer cell apoptosis by activation of extrinsic apoptotic pathways

Shi,Lin‑Sen; Wang,Hao; Wang,Feng; Feng,Min; Wang,Meng; Guan,Wen‑Xian

doi:10.3892/mmr.2014.2603

Effects of gastrokine‑2 expression on gastric cancer cell apoptosis by activation of extrinsic apoptotic pathways

Authors:
- Lin‑Sen Shi
- Hao Wang
- Feng Wang
- Min Feng
- Meng Wang
- Wen‑Xian Guan
View Affiliations

Affiliations: Department of Gastrointestinal Surgery, The Drum Tower Clinical College of Nanjing Medical University, Nanjing, Jiangsu 210008, P.R. China
Published online on: September 30, 2014 https://doi.org/10.3892/mmr.2014.2603
Pages: 2898-2904
Copyright: © Shi et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Gastrokine‑2 is a putative gastric cancer‑specific tumor suppressor gene, the loss of which is known to be involved in the development and progression of gastric cancer, and restoration of gastrokine‑2 expression inhibits growth of gastric cancer cells in vitro. However, the underlying mechanism of these effects requires elucidation. In the present study, expression patterns of gastrokine‑2 protein were examined in gastric cancer tissues and cell lines. Expression of gastrokine‑2 was restored in gastric cancer cells in order to assess its effect on cell viability, apoptosis and gene expression. A total of 76 gastric cancer tissues with corresponding normal mucosae samples, and two gastric cancer cell lines (SGC‑7901 and AGS) were subjected to western blot analysis of gastrokine‑2 expression. SGC‑7901 cells were transiently transfected with gastrokine‑2 cDNA and then treated with anti‑CD95 and/or anti‑Fas antibodies prior to analysis of cell viability, apoptosis and gene expression levels. Expression of gastrokine‑2 protein was reduced or absent in gastric cancer tissues and gastric cancer cell lines. Following restoration of gastrokine‑2 expression, the protein expression level of Fas was significantly increased, but no marked change was observed in the levels of bcl‑2 and Bax proteins. Expression of gastrokine‑2 protein reduced gastric cancer cell viability and induced apoptosis. Activity of caspase‑3 and caspase‑8 was increased, but caspase‑9 activity remained unchanged in the SGC‑7901 cells. Reduction or knockout of gastrokine‑2 protein expression may contribute to gastric cancer development or progression, as the current study demonstrated that restoration of gastrokine‑2 expression induces apoptosis of gastric cancer cells through the extrinsic apoptosis pathway.

View Figures

View References

1	Forman D and Burley VJ: Gastric cancer: global pattern of the disease and an overview of environmental risk factors. Best Pract Res Clin Gastroenterol. 20:633–649. 2006. View Article : Google Scholar : PubMed/NCBI
2	Hohenberger P and Gretschel S: Gastric cancer. Lancet. 362:305–315. 2003. View Article : Google Scholar
3	Leung WK, Wu MS, Kakugawa Y, et al: Asia Pacific Working Group on Gastric Cancer: Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol. 9:279–287. 2008. View Article : Google Scholar : PubMed/NCBI
4	Soerjomataram I, Lortet-Tieulent J, Parkin DM, et al: Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions. Lancet. 380:1840–1850. 2012.PubMed/NCBI
5	Yoshida T, Ono H, Kuchiba A, et al: Genome-wide germline analyses on cancer susceptibility and GeMDBJ database: Gastric cancer as an example. Cancer Sci. 7:1582–1589. 2010. View Article : Google Scholar : PubMed/NCBI
6	Mirvish SS: Gastric cancer and salivary nitrate and nitrite. Nature. 315:461–462. 1985. View Article : Google Scholar : PubMed/NCBI
7	Parsonnet J, Friedman GD, Vandersteen DP, et al: Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med. 325:1127–1131. 1991. View Article : Google Scholar
8	Lo SS, Wu CW, Hsieh MC, et al: Relationship between age and clinical characteristics of patients with gastric cancer. J Gastroenterol Hepatol. 11:511–514. 1996. View Article : Google Scholar : PubMed/NCBI
9	Hwang H, Dwyer J and Russell RM: Diet, Helicobacter pylori infection, food preservation and gastric cancer risk: are there new roles for preventative factors? Nutr Rev. 52:75–83. 1994.
10	Roberts-Thomson IC and Butler WJ: Polymorphism and gastric cancer. J Gastroenterol Hepatol. 20:793–794. 2005. View Article : Google Scholar : PubMed/NCBI
11	Du JJ, Dou KF, Peng SY, et al: Down-regulated full-length novel gene GDDR and its effect on gastric cancer. Zhonghua Yi Xue Za Zhi. 83:1166–1168. 2003.(In Chinese).
12	Sánchez-Pulido L, Devos D and Valencia A: BRICHOS: a conserved domain in proteins associated with dementia, respiratory distress and cancer. Trends Biochem Sci. 27:329–332. 2002.PubMed/NCBI
13	Oien KA, McGregor F, Butler S, et al: Gastrokine 1 is abundantly and specifically expressed in superficial gastric epithelium, down-regulated in gastric carcinoma, and shows high evolutionary conservation. J Pathol. 203:789–797. 2004. View Article : Google Scholar
14	Westley BR, Griffin SM and May FE: Interaction between TFF1, a gastric tumor suppressor trefoil protein, and TFIZ1, a brichos domain-containing protein with homology to SP-C. Biochemistry. 44:7967–7975. 2005. View Article : Google Scholar : PubMed/NCBI
15	Du JJ, Dou KF, Peng SY, et al: Study on novel gene GDDR related to gastric cancer. Zhonghua Wai Ke Za Zhi. 43:10–13. 2005.(In Chinese).
16	Chu G, Qi S, Yang G, et al: Gastrointestinal tract specific gene GDDR inhibits the progression of gastric cancer in a TFF1 dependent manner. Mol Cell Biochem. 359:369–374. 2012. View Article : Google Scholar : PubMed/NCBI
17	Baus-Loncar M, Lubka M, Pusch CM, et al: Cytokine regulation of the trefoil factor family binding protein GKN2 (GDDR/TFIZ1/blottin) in human gastrointestinal epithelial cells. Cell Physiol Biochem. 20:193–204. 2007.
18	Reed JC: Mechanisms of apoptosis. Am J Pathol. 157:1415–1430. 2000. View Article : Google Scholar
19	Jin Z and El-Deiry WS: Overview of cell death signaling pathways. Cancer Biol Ther. 4:139–163. 2005.PubMed/NCBI
20	Carrington PE, Sandu C, Wei Y, et al: The structure of FADD and its mode of interaction with procaspase-8. Mol Cell. 22:599–610. 2006. View Article : Google Scholar
21	Roy MK, Thalang VN, Trakoontivakorn G and Nakahara K: Mahanine, a carbazole alkaloid from Micromelum minutum, inhibits cell growth and induces apoptosis in U937 cells through a mitochondrial dependent pathway. Br J Pharmacol. 145:145–155. 2005.
22	Henkler F, Behrle E, Dennehy KM, et al: The extracellular domains of FasL and Fas are sufficient for the formation of supramolecular FasL-Fas clusters of high stability. J Cell Biol. 168:1087–1098. 2005. View Article : Google Scholar : PubMed/NCBI
23	Ashkenazi A and Dixit VM: Death receptors: signaling and modulation. Science. 281:1305–1308. 1998. View Article : Google Scholar : PubMed/NCBI
24	Thorburn A: Death receptor-induced cell killing. Cell Signal. 16:139–144. 2004. View Article : Google Scholar
25	Houston A and O’Connell J: The Fas signalling pathway and its role in the pathogenesis of cancer. Curr Opin Pharmacol. 4:321–326. 2004. View Article : Google Scholar : PubMed/NCBI
26	Mollinedo F and Gajate C: Fas/CD95 death receptor and lipid rafts: new targets for apoptosis-directed cancer therapy. Drug Resist Updat. 9:51–73. 2006. View Article : Google Scholar : PubMed/NCBI
27	Zheng HC, Sun JM, Wei ZL, et al: Expression of Fas ligand and caspase-3 contributes to formation of immune escape in gastric cancer. World J Gastroenterol. 9:1415–1420. 2003.PubMed/NCBI
28	Boroumand-Noughabi S, Sima HR, Ghaffarzadehgan K, et al: Soluble Fas might serve as a diagnostic tool for gastric adenocarcinoma. BMC Cancer. 10:2752010. View Article : Google Scholar : PubMed/NCBI
29	Li Z, Wang Z, Zhao Z, et al: Expression of Fas, FasL and IFN-gamma in gastric cancer. Beijing Da Xue Xue Bao. 35:386–389. 2003.PubMed/NCBI
30	Gryko M, Guzińska-Ustymowicz K, Pryczynicz A, et al: Correlation between Fas and FasL proteins expression in normal gastric mucosa and gastric cancer. Folia Histochem Cytobiol. 49:142–147. 2011. View Article : Google Scholar : PubMed/NCBI
31	Kouznetsova I, Laubinger W, Kalbacher H, et al: Biosynthesis of gastrokine-2 in the human gastric mucosa: restricted spatial expression along the antral gland axis and differential interaction with TFF1, TFF2 and mucins. Cell Physiol Biochem. 20:899–908. 2007. View Article : Google Scholar
32	Otto WR, Patel K, McKinnell I, et al: Identification of blottin: a novel gastric trefoil factor family-2 binding protein. Proteomics. 6:4235–4245. 2006. View Article : Google Scholar : PubMed/NCBI
33	Moss SF, Lee JW, Sabo E, et al: Decreased expression of gastrokine 1 and the trefoil factor interacting protein TFIZ1/GKN2 in gastric cancer: influence of tumor histology and relationship to prognosis. Clin Cancer Res. 14:4161–4167. 2008. View Article : Google Scholar : PubMed/NCBI
34	Resnick MB, Sabo E, Meitner PA, et al: Global analysis of the human gastric epithelial transcriptome altered by Helicobacter pylori eradication in vivo. Gut. 55:1717–1724. 2006. View Article : Google Scholar : PubMed/NCBI
35	Rippa E, La Monica G, Allocca R, et al: Overexpression of gastrokine-1 in gastric cancer cells induces Fas-mediated apoptosis. J Cell Physiol. 226:2571–2578. 2011. View Article : Google Scholar : PubMed/NCBI